Limits how many patents a plaintiff may assert in a single patent lawsuit over certain drugs and biological products: a plaintiff can assert at most one patent from a defined “Patent Group” against covered applicants, approval holders, or makers/sellers of approved products. The rule applies to applications submitted on or after the Act’s enactment and defines the Patent Group by reference to certain disclaimer language.